Drag a card by its title · ⚙ to size, swap or remove

The company

Biodesix, Inc.

BDSX · Nasdaq

Health CareDiagnostics & LabsLeading

BDSX stood above a rising 150-day average in 41 of the last 52 weekly readings, including each of the last 41 weeks. It is 17.0% above that average now. Diagnostics & Labs: 50% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 41 in a row
Industry in uptrend: 50% +2 in 4 wk
Insider buys, 12 months: $6.2M
Insider sales, 12 months: $234K
Officials’ trades on record: 0
Institutions holding: 45 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 41 of 52 weeks.

20 Apr – 19 Oct

Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6

Sale orders, 12 months20

Buyers · sellers1 · 5

Who	Did	Shares	Traded
Jack W. Schuler10% owner, Other	bought	15,000at $24.47	12 Aug 2026filed 13 Aug 2026
Jack W. Schuler10% owner, Other	bought	13,700at $24.01	11 Aug 2026filed 12 Aug 2026
Jack W. Schuler10% owner, Other	bought	13,900at $24.25	10 Aug 2026filed 12 Aug 2026
Kieran O'KaneChief Commercial Officer	sold	535at $12.78	23 Feb 2026filed 23 Feb 2026
Gary Anthony PestanoChief Development Officer	sold	556at $12.78	23 Feb 2026filed 23 Feb 2026
Scott HuttonPresident & CEO	sold	1,490at $12.78	23 Feb 2026filed 23 Feb 2026
Robin Harper CowieCFO, Sec'y & Treasurer	sold	535at $12.78	23 Feb 2026filed 23 Feb 2026
Chris VazquezChief Accounting Officer	sold	211at $12.78	23 Feb 2026filed 23 Feb 2026
Scott HuttonPresident & CEO	sold	3,559at $10.08	10 Feb 2026filed 11 Feb 2026
Gary Anthony PestanoChief Development Officer	sold	540at $10.08	10 Feb 2026filed 11 Feb 2026
Kieran O'KaneChief Commercial Officer	sold	584at $10.08	10 Feb 2026filed 11 Feb 2026
Chris VazquezChief Accounting Officer	sold	101at $10.08	10 Feb 2026filed 11 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders45+6 on the quarter

New · exited11 · 5

Reported value$97.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
AIGH Capital Management LLCreduced · filed 7 Aug 2026	678,328$15.3M	-80,000−10.5%
Soleus Capital Management, L.P.added · filed 11 Aug 2026	585,958$13.2M	+169,359+40.7%
Telemark Asset Management, LLCunchanged · filed 10 Aug 2026	489,824$11.0M	00.0%
Aberdeen Group plcreduced · filed 31 Jul 2026	388,639$8.8M	-69,799−15.2%
Birchview Capital, LPunchanged · filed 14 Aug 2026	286,804$6.5M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	284,169$6.4M	+29,008+11.4%
ESSEX INVESTMENT MANAGEMENT CO LLCadded · filed 6 Aug 2026	241,915$5.5M	+109,829+83.1%
Opaleye Management Inc.reduced · filed 14 Aug 2026	180,000$4.1M	-58,047−24.4%
MARSHALL WACE, LLPreduced · filed 13 Aug 2026	116,199$2.6M	-25,437−18.0%
PERCEPTIVE ADVISORS LLCnew · filed 14 Aug 2026	108,694$2.5M	+108,694